| Unique ID issued by UMIN | UMIN000053892 |
|---|---|
| Receipt number | R000061466 |
| Scientific Title | Evaluation of the impact of foods containing probiotics from a person's gut microbiota on that their gut microbiota |
| Date of disclosure of the study information | 2025/04/01 |
| Last modified on | 2025/09/17 12:59:05 |
Evaluation of the impact of foods containing probiotics from a person's gut microbiota on that their gut microbiota
Evaluation of the impact of foods containing probiotics from a person's gut microbiota on that their gut microbiota
Evaluation of the impact of foods containing probiotics from a person's gut microbiota on that their gut microbiota
Evaluation of the impact of foods containing probiotics from a person's gut microbiota on that their gut microbiota
| Japan |
Healthy adult
| Adult |
Others
NO
Evaluation of the impact of foods containing probiotics from a person's gut microbiota on that their gut microbiota
Safety,Efficacy
Relative abundance of Bifidobacterium
Gut microbiota analysis
Subjective evaluation questionnaire on depression, activity levels, and sleep quality
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
| Food |
Intake test food for 1week > follow up for 3 weeks
| 20 | years-old | <= |
| 60 | years-old | > |
Male and Female
1. Male and female participants aged 20 to under 60 years at the time of consent acquisition.
2. Individuals who have received sufficient explanation about the trial, can understand its content, and from whom consent has been obtained personally.
1. Individuals who regularly use specific health foods, functional foods, health supplements, supplements, probiotics, etc., more than three times a week, which could potentially affect the trial, and cannot discontinue them from the time of consent acquisition.
2. Individuals who have taken medications (e.g., antibiotics, intestinal regulators, laxatives, etc.) that may potentially affect the trial within 3 months prior to consent acquisition.
3. Individuals deemed unsuitable as trial subjects based on the responses to the background survey in the preliminary investigation.
4. Heavy alcohol drinkers.
5. Individuals with a history or current presence of serious diseases of the heart, liver, kidneys, digestive system, etc.
6. Pregnant, breastfeeding, or individuals intending to become pregnant during the trial period.
7. Individuals with allergies to medications or food.
8. Individuals participating in other clinical trials for drugs or health foods, within 4 weeks after the end of such trials, or planning to participate in another clinical trial after consenting to participate in this trial.
9. Individuals whom the trial investigator deems inappropriate for participation in the study.
30
| 1st name | Natsuki |
| Middle name | |
| Last name | Suganuma |
bacterico
Research and Development Department
530-0027
7th Floor, Sankyo Umeda Building, 1-5 Douyamacho, Kita-ku, Osaka City, Osaka Prefecture
06-4397-3516
info@bacterico.co.jp
| 1st name | Natsuki |
| Middle name | |
| Last name | Suganuma |
bacterico
Research and Development Department
530-0027
7th Floor, Sankyo Umeda Building, 1-5 Douyamacho, Kita-ku, Osaka City, Osaka Prefecture
06-4397-3516
info@bacterico.co.jp
Bacterico
self funding
Self funding
Chiyoda Paramedical Care Clinic Ethics Committee
2nd Floor, Daiwa Building, 3-3-10 Nihonbashi Honcho, Chuo-ku, Tokyo
03-6225-9005
IRB@cpcc.co.jp
NO
| 2025 | Year | 04 | Month | 01 | Day |
Unpublished
Completed
| 2023 | Year | 11 | Month | 28 | Day |
| 2023 | Year | 12 | Month | 03 | Day |
| 2024 | Year | 01 | Month | 31 | Day |
| 2025 | Year | 03 | Month | 31 | Day |
| 2024 | Year | 03 | Month | 18 | Day |
| 2025 | Year | 09 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061466